Edition:
Deutschland

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

47.51EUR
09:38 Uhr
Change (% chg)

€-0.14 (-0.29%)
Prev Close
€47.65
Open
€48.00
Day's High
€48.10
Day's Low
€47.47
Volume
155,261
Avg. Vol
1,542,894
52-wk High
€52.82
52-wk Low
€40.45

About

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes... (more)

Buy/Sell

Sell Hold Buy
2.08 Mean rating from 24 analysts

Overall

Beta: 0.56
Market Cap(Mil.): €39,028.29
Shares Outstanding(Mil.): 554.54
Dividend: 0.62
Yield (%): 0.88
Photo

Fresenius forecasts 2020 profit growth driven by drug, dialysis units

German healthcare group Fresenius said it expects net income to increase in 2020 after strong growth in its dialysis business, and in its infusion drugs unit in emerging markets, helped it to just beat fourth quarter expectations.

UPDATE 3-Fresenius forecasts 2020 profit growth driven by drug, dialysis units

* Kabi most exposed to coronavirus, but plays down overall effect

BRIEF-Fresenius CEO Says Biggest Exposure From Coronavirus On Unit Kabi

* CEO SAYS BIGGEST EXPOSURE FROM CORONAVIRUS IS ON FRESENIUS KABI

BRIEF-Fresenius Q4 EBIT Slightly Above Estimates At EUR 1.29 Bln

* Q4 REVENUE 9.3 BILLION EUR, UP 6% (VERSUS F'CAST 9.34 BILLION EUR)

BRIEF-Fresenius Kabi And Vifor Pharma Create JV In China For I.V. Iron Portfolio

* FRESENIUS KABI AND VIFOR PHARMA CREATE JOINT VENTURE IN CHINA FOR I.V. IRON PORTFOLIO

Fresenius forecasts 2020 sales growth driven by drug, dialysis units

Feb 20 German healthcare group Fresenius forecast 2020 revenue growth on Thursday, saying growth of its infusion drugs unit in emerging markets partially offset softer development in North America in the fourth quarter and noting strong growth of its dialysis business.

German stocks - Factors to watch on February 20

BERLIN/FRANKFURT, Feb 19 The following are some of the factors that may move German stocks on Thursday:

Photo

Fresenius Medical says fourth-quarter operating profit up 3%

FRANKFURT Germany's Fresenius Medical Care on Wednesday said quarterly adjusted operating income edged 3% higher as growth in dialysis services and products was partly offset by a negative adjustment for accounts receivable in a legal dispute in North America.

Fresenius Medical says fourth quarter operating profit up 3%

FRANKFURT Germany's Fresenius Medical Care on Wednesday said quarterly adjusted operating income edged 3% higher as growth in dialysis services and products was partly offset by a negative adjustment for accounts receivable in a legal dispute in North America.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.50%
Rohstoffe -0.84%
Industrie -0.56%
Konjunktur abhängige Waren & Dienstleistungen -0.40%
Konjunktur unabhängige Waren & Dienstleistungen -0.24%
Finanzindustrie -0.26%
Pharma -0.15%
Technologie -0.45%
Telekommunikation -0.18%

Nachrichten aus der Wirtschaft